Daxor Co. (NASDAQ:DXR – Get Free Report) saw a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 8,900 shares, a growth of 20.3% from the January 15th total of 7,400 shares. Currently, 0.5% of the company’s stock are short sold. Based on an average […]
Daxor (NASDAQ:DXR – Get Free Report) and Sintx Technologies (NASDAQ:SINT – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, risk, profitability, valuation and dividends. Volatility and Risk Daxor has a beta of […]
Daxor Co. (NASDAQ:DXR – Get Free Report) was the recipient of a significant decline in short interest in November. As of November 30th, there was short interest totalling 9,600 shares, a decline of 13.5% from the November 15th total of 11,100 shares. Based on an average daily volume of 1,900 shares, the short-interest ratio is […]
Daxor Co. (NASDAQ:DXR – Get Free Report) shares fell 5.2% during mid-day trading on Tuesday . The stock traded as low as $8.84 and last traded at $8.84. 3,645 shares were traded during mid-day trading, a decline of 41% from the average session volume of 6,159 shares. The stock had previously closed at $9.33. Daxor […]